08.05.22 -- Patient-Centric Drug Design And Dose Development

Learn more about new technologies for developing and delivering optimal dosage forms that address adherence and acceptability in pediatric populations.

Custom-designed equipment and suites, flexible manufacturing lines, and alternative delivery and manufacturing approaches are critical to achieving a timely launch in a competitive marketplace.

Whether you are considering an orally disintegrating tablet to enhance pharmacokinetics through pregastric absorption, to improve patient compliance, or to gain a marketing advantage for a valued brand, Zydis® fast dissolve can help enhance the value of your investment and increase your product’s potential.

ALK-Abelló, a global research-driven pharmaceutical company that focuses on the prevention, diagnosis, and treatment of allergies, transitioned their allergen immunotherapies from injection to oral delivery, which resulted in a marked improvement in patient tolerability, preference, and compliance.